Full Press Release Details
Immutep Granted Japanese Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination.
IMMP
Immutep Granted Japanese Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination
Key Takeaway: Immutep Granted Japanese Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination